G
GRCE
Grace Therapeutics, Inc
2.120
+0.020+0.95%After Hours: 2.120 0.000 0.00%19:30 09/08 EDT
OPEN/PREV CLOSE2.090/2.100
TODAY RANGE2.050-2.135
VOL159.47K
MARKET CAP44.60M
52 WEEK RANGE1.790-5.18
AVG VOL (3M)215.64K
% TURNOVER0.76%
TURNOVER--
P/E (TTM)-1.7994
% RANGE4.03%
EPS(TTM)-1.1782
P/E(FORWARD)-0.3384
P/B0.7156
BVPS2.963
DIVIDEND--
P/S33.92
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP36.48M
SHARES OUTSTANDING21.04M
NEXT EARNINGS--
FREE FLOAT17.21M
LOT SIZE1
EX-DATE07/10/2023
News
Press Releases
Financial Reports
Profile
TipRanks·08/24 20:15
Grace Therapeutics files to sell 4.76M shares of common stock for holders
TipRanks·08/20 02:08
Major Investor Quietly Boosts Stake in Grace Therapeutics With Fresh Buy-In
TipRanks·08/18 13:15
Grace Therapeutics (GRCE) Receives a Rating Update from a Top Analyst
Seeking Alpha·08/13 19:07
Grace Therapeutics GAAP EPS of -$0.91
Benzinga·08/13 12:23
Grace Therapeutics Q1 EPS $(0.91) Misses $(0.18) Estimate
Dow Jones·08/13 12:03
*Grace Therapeutics 1Q Loss/Shr 91c >GRCE
Dow Jones·08/13 12:03
*Grace Therapeutics 1Q Loss $15.8M >GRCE
Dow Jones·08/13 12:00
Press Release: Grace Therapeutics Announces First -2-
TipRanks·08/06 21:09
Grace Therapeutics Raises Capital to Advance GTx-104 Program
TipRanks·08/05 09:35
Grace Therapeutics to issue 4.762M shares at $2.10 in private placement
TipRanks·08/05 09:35
Grace Therapeutics initiates dual-source manufacturing strategy for GTx-104
Seeking Alpha·08/05 07:03
Grace Therapeutics prices $10M private placement
Same Industry
Name/Symbol
Change%
Price